Vivante Health Raises $31M in Series B Funding

Vivante Health, a Chicago, IL-based digital digestive health company, raised $31M in Series B funding.

The round, which brought the total amount to $47M, was led by Health Catalyst Capital, with participation from returning investors 7wireVentures, Intermountain Ventures, Distributed Ventures, Human Capital, and SemperVirens.

The company intends to use the funds to support continued technology upgrades designed to predict the onset and progression of GI conditions and provide complete virtual care for digestive disorders, and ongoing expansion of its commercial and client support teams along with onboarding support for new employers, health plans, and channel partners.

Led by CEO Bill Snyder, Vivante Health is digital healthcare company providing a virtual GI care that delivers care by pairing data-driven technology with a coordinated team of physicians, registered dietitians and health coaches.

The new funding follows recent GIThrive enhancements that spotlight the platform’s ability to provide the right care at the right time. In addition to food and symptom logging, online educational resources and 24/7 access to dietitians, health coaches and nurses, users now receive AI-driven personalized care plans that dynamically adjust to their symptoms and other variables; access to a nationwide network of internists and gastroenterologists for diagnosis, treatment, lab test orders and prescriptions; and other new services that help bridge the gap between virtual and real-world care.